Financial Stability Oversight Council Improvement Act of 2025

1) What happened and its current status: On June 3, 2025, Rep. Foster (D-IL) introduced HR 3682 in the House. The bill was reported out of the Financial Services Committee (47-4) on November 4, 2025, and passed the House under suspension of the rules on February 9, 2026 (15 actions total, indicating strong legislative momentum). A companion bill (S3578) was introduced in the Senate and referred to the Banking Committee. This is not yet law — the Senate must pass its version or the House bill before the President can sign. 2) The money trail: This bill does not authorize or appropriate any funding. It is a procedural reform that modifies the regulation of nonbank financial companies. The economic impact is entirely about reducing the probability and cost of future regulatory designation. The bill requires FSOC to determine that alternative actions are 'impracticable or insufficient' before voting on a designation — this creates a legal and procedural hurdle that makes designations harder. For the targeted companies, this is equivalent to removing a potential liability: the cost of Fed supervision would include capital requirements, stress testing, and compliance burdens that could run tens of millions annually per firm. 3) Structural winners: The companies most directly affected are large nonbank financial firms that were previously designated (MetLife was designated and later de-designated) or currently face risk. Berkshire Hathaway, Blackstone, PayPal, Visa, and Mastercard are all firms with scale and market footprint that make them candidates for future FSOC scrutiny. The bill reduces — but does not eliminate — that risk. Pure-play asset managers like Blackstone are most affected, as their business models rely on leverage and capital deployment that could be constrained under Fed oversight. 4) Market data analysis: Real market data shows mixed recent performance across the affected tickers. BRK-B is up 2.74% (7-day) and 2.06% (30-day), trading at $478.16 near the middle of its 52-week range ($455.19-$542.07). BX is down 6.33% in 7 days but up 12.45% over 30 days, trading at $121.52 — well below its 52-week high of $190.09. PYPL is down 3.08% (7-day) but up 13.88% (30-day), at $49.64, near its 52-week low of $38.46. V is down 0.64% (7-day) and up 4.66% (30-day) at $309.3, near its 52-week low of $293.89. MA is down 0.50% (7-day) and up 4.83% (30-day) at $507.62, also near its 52-week low. The 7-day declines for BX, PYPL, V, and MA appear to be market pullbacks unrelated to this bill; the bill's favorable House passage occurred on Feb 9 and has been priced in structurally. 5) Timeline: The bill must pass the Senate. The companion bill (S3578) is identical and has been referred to the Senate Banking Committee. Given the bipartisan House vote (47-4 in committee, passed under suspension) and broad cosponsor base (20 cosponsors across parties), Senate passage is plausible but not guaranteed in the current session. If passed, the President would likely sign given the bipartisan nature.